Skip to main content
. 2021 Aug 3;27(4):234–239. doi: 10.4103/sjg.sjg_563_20

Table 4.

Subgroup analysis for screening colonoscopy indication

Reasons for colonoscopy Single Dose (n=120)
Split Dose (n=120)
Adequate Bowel Preparation
P Adequate Bowel Preparation
P
Yes n (%) No n (%) Yes n (%) No n (%)
History of polyps 1 (25.0) 3 (75.0) 0.148 11 (84.6) 2 (15.4) 0.632
Screening (no personal history of polyps or cancer) 12 (70.6) 5 (29.4) 0.592 15 (93.8) 1 (6.3) 1.000
Change in bowel habits 26 (60.5) 17 (39.5) 0.844 34 (79.1) 9 (20.9) 0.013
Inflammatory bowel disease 19 (82.6) 4 (17.4) 0.032 17 (94.4) 1 (5.6) 0.689
Rectal bleeding 10 (52.6) 9 (47.4) 0.439 18 (90.0) 2 (10.0) 1.000
Cancer surveillance (follow-up evaluation) 2 (50.0) 2 (50.0) 0.630 5 (100) 0 (0) 1.000
Anemia 4 (44.4) 5 (55.6) 0.293 8 (100) 0 (0) 0.597
Others 10 (62.5) 6 (37.5) 1.000 19 (86.4) 3 (13.6) 0.704